Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Anti-microbial technology company Byotrol said it swung to a small annual profit, but its shares were suspended from trading after it was unable to file an audited version of its results on time.
Posting unaudited accounts, the company said it made a pre-tax profit for the year through March of £0.23m, compared to a loss of £1.57m on-year.
Revenue jumped to £5.66m, up from £1.82m, but was offset by sales, R&D and administrative costs.
Byotrol said it could not lodge audited accounts by the end-September deadline because of complexities associated with its acquisition of Medimark and the restatement of its 2018 results for the effects of IFRS 15 accounting standards.
'We are now in the process of finalising the audit process for the year and the accounts will be published as soon as possible,' it said.
At 1:36pm: (LON:BYOT) Byotrol PLC share price was -0.12p at 1.93p